1. Prologue to Breast Cancer and Lumpectomy

  1.1 Lumpectomy - A Breast Conserving Strategy

  1.2 A Safer and Efficient Alternative to Mastectomy

2. Lumpectomy - Opportunities in the US Breast Cancer Therapy Market

  2.1 US Breast Cancer Market Size

  2.2 Increasing Breast Cancer Incidence in the US

  2.3 Combination of Lumpectomy and Radiation - Equivalent Efficacy to Mastectomy

    2.3.1 Mastectomy v/s Lumpectomy Preference in American Women

    2.3.2 Overall Survival and Recurrence Rates

3. Lumpectomy - Procedure and Cost Involved

  3.1 Breast Cancer Mammogram and Biopsy Cost

  3.2 Cost Involved During the Procedure

    3.2.1 Lumpectomy plus Whole-Breast Radiation Therapy

    3.2.2 Lumpectomy plus Partial-Breast Radiation Therapy (Brachytherapy)

  3.3 Lumpectomy and Mastectomy Reimbursement Analysis

  3.4 Post Lumpectomy Costs

    3.4.1 Mastectomy or Mastectomy Plus Reconstruction

    3.4.2 Additional Cost (Consumable, Lab, Imaging and Other Service Cost)

  3.5 Cost Effectiveness of Lumpectomy

4. Current Market Scenario and Trends in Lumpectomy Breast Cancer Treatment

  4.1 Rise in Breast Cancer Screening among American Women

    4.1.1 Entry of Advanced Breast Imaging Techniques

    4.1.2 Rising Awareness Regarding Breast Cancer Screening

    4.1.3 Breast Cancer Incidence and Lumpectomy Preference in Men

  4.2 Rise in Clinical Studies Proving Better Efficacy of Lumpectomy

5. Lumpectomy Market Analysis by Technology

  5.1 MarginProbe - An Intra Operative Technology to Improve Lumpectomy

  5.2 Savi Scout-Breast Localization and Surgical Guidance System

  5.3 Biozorb LP for Better Cosmetic Outcome after Lumpectomy

6. Key Developments Affecting the US Lumpectomy Market

  6.1 Focus of Key Industries in Early Stage Breast Cancer Segment

  6.2 Introduction of Better Breast Cancer Screening Technology and Its Impact on the Lumpectomy Market

  6.3 Expansion of US Lumpectomy Technology and Products to Global Platforms

    6.3.1 iCAD Early Breast Cancer Screening Technology

    6.3.2 Intrabeam System by Carl Zeiss Meditech

7. New and Better Breast Imaging Technology Driving Lumpectomy Market

  7.1 Digital Breast Tomosynthesis (DBT)

  7.2 Breast Cancer Genetic Screening Tests on the Rise

  7.3 FDA Approval of Innovative Lumpectomy Technology

  7.4 Magnetic MaMaLoc Technology – Localized Lumpectomy Procedure

8. Presence of Venture Capitalist influencing the US Breast Cancer Lumpectomy Segment

9. Porter’s Five Force Analysis of the Breast Lumpectomy Market

  9.1 Threat of New Entrant

  9.2 Bargaining Power of Patient

  9.3 Bargaining Power of Service Providers

  9.4 Intensity of Competitive Rivalry

  9.5 Threat of Substitutes Procedures

10. Lumpectomy Market Analysis by End User

  10.1 Hospitals

  10.2 Oncology Research and Screening Centers

11. US Lumpectomy Market Dynamics

  11.1 Market Driving Parameters

  11.2 Market Growth and Acceptability Challenges

12. Future Forecast and Projections of the Lumpectomy Market

13. Competitive Analysis

  13.1 Carl Zeiss Meditech

  13.2 Cianna Medical

  13.3 Clear Cut Medical

  13.4 Dune Medical Devices

  13.5 Endomagnetics

  13.6 Focal Therapeutics

  13.7 Hologic

  13.8 iCAD

  13.9 Medtronic

  13.10 Sanarus

Figure 1-1: Overview of Lumpectomy

Figure 1-2: Treatment Algorithm in Early Breast Cancer Patients

Figure 1-3: Global-Five Year Survival Rate in Breast Cancer by Stage

Figure 1-4: Lumpectomy v/s Mastectomy Overview

Figure 2-1: US v/s Rest of the World - Breast Cancer Market Size (%), 2018

Figure 2-2: US - Breast Cancer Prevalence and Incidence (Patients/Year), 2016-2018

Figure 2-3: US - Probability of Developing Breast Cancer in Women by Age(%), 2018

Figure 2-4: US - Probability of Breast Cancer by Ethnicity (%), 2018

Figure 2-5: Lumpectomy and Mastectomy - Estimated Market Size (%), 2018

Figure 2-6: US - Mastectomy v/s Lumpectomy Preference (%) , 2018

Figure 2-7: US - Five Year Survival Rate in Women (%), 2018

Figure 2-8: US - Five Year Survival Rate in Men (%), 2018

Figure 2-9: Efficacy of Lumpectomy v/s Mastectomy (%)

Figure 3-1: US - Lumpectomy Treatment Cost by Stage of Breast Cancer (US$/Patient), 2018

Figure 3-2: US - Lumpectomy Breast Surgery Cost (US$), 2018

Figure 3-3: Lumpectomy - General Overview of the Procedure

Figure 3-4: US - Mammogram Cost Analysis (US$/Test), 2018

Figure 3-5: US- Biopsy and Mammography Cost (US$/Patient), 2018

Figure 3-6: Recent Alternatives to Breast Cancer Biopsy

Figure 3-7: US - ONCOblot and Thermography Cost Analysis (US$), 2018

Figure 3-8: US - Whole Breast and Partial Breast Radiation Therapy Cost Analysis (US$), 2018

Figure 3-9: US - Average Lumpectomy plus Whole Breast Radiation Cost (US$), 2018

Figure 3-10: Intrabeam - Single Dose Radiation Therapy Cost Analysis (US$), 2018

Figure 3-11: US - Lumpectomy plus Breast Radiation Cost (US$), 2018

Figure 3-12: US - Mastectomy and Lumpectomy Reimbursement Analysis (US$), 2018

Figure 3-13: US - Breast Reconstruction Surgery Cost (US$), 2018

Figure 3-14: US - Breast Reconstruction Cost Post Lumpectomy (US$), 2018

Figure 3-15: US - Average Consumable, Lab and Additional Service Cost in Lumpectomy (US$/Patient), 2018

Figure 3-16: Comparative Cost Analysis of Mastectomy and Lumpectomy (US$), 2018

Figure 4-1: US - USPTF Estimated Screening Cost (US$ Billion)

Figure 4-2: US - Digital Mammography System Equipment Cost (US$), 2018

Figure 4-3: US - Epidemiology (Estimate) of Breast Cancer by Gender, 2018

Figure 5-1: Marginprobe - A Recent Advancement in the Lumpectomy Segment

Figure 5-2: MargineProbe - Clinical Efficacy Data proving it Efficacy (%), 2018

Figure 5-3: MarginProbe - Breast Re-Excision Reduction Rate (%), 2018

Figure 5-4: Savi Scout - Feature Overview

Figure 6-1: Sentimag - Key Features in Lumpectomy

Figure 6-2: Intrabeam - An Insight into its Key Features

Figure 6-3: US v/s Rest of the World-Intrabeam Centers (Number), 2018

Figure 7-1: Advantages of Novel Breast Tomography Technique over 2D Technology

Figure 7-2: Magnetic MaMaLoc Technology - Overview

Figure 8-1: US - Emerging Markets Affecting the Lumpectomy Segment

Figure 9-1: US - Lumpectomy Marker - Porter's Five Force Analysis

Figure 10-1: US - Recommended Frequency of Breast Cancer Screening by Age

Figure 10-2: US - Lumpectomy Market Size by End User (%), 2018

Figure 10-3: US - Out Patient Department Visits for Breast Cancer (Patients/State), 2017

Figure 10-4: US - Lumpectomy and Mastectomy Payment Source Analysis by Patients (Number), 2017

Figure 10-5: US - Cancer Research Funds across Major Research Centers (US$ Million), 2017

Figure 11-1: Driving Factors of the Lumpectomy Market

Figure 11-2: US - Lumpectomy Market Challenges

Figure 12-1: US - Lumpectomy Market Future Forecast (US$ Billion), 2017-2024